Browse

You are looking at 1 - 10 of 761 items

Tobias Winkler Charité – Universitätsmedizin Berlin, corporate member of Freie Universität Berlin and Humboldt-Universität zu Berlin, Center for Musculoskeletal Surgery, Berlin, Germany
Berlin Institute of Health at Charité – Universitätsmedizin Berlin, Julius Wolff Institute, Berlin, Germany
Berlin Institute of Health Center for Regenerative Therapies, Berlin Institute of Health at Charité – Universitätsmedizin Berlin, Berlin, Germany

Search for other papers by Tobias Winkler in
Google Scholar
PubMed
Close
,
Sven Geissler Berlin Institute of Health at Charité – Universitätsmedizin Berlin, Julius Wolff Institute, Berlin, Germany
Berlin Institute of Health Center for Regenerative Therapies, Berlin Institute of Health at Charité – Universitätsmedizin Berlin, Berlin, Germany

Search for other papers by Sven Geissler in
Google Scholar
PubMed
Close
,
Tazio Maleitzke Berlin Institute of Health Center for Regenerative Therapies, Berlin Institute of Health at Charité – Universitätsmedizin Berlin, Berlin, Germany
Trauma Orthopaedic Research Copenhagen Hvidovre (TORCH), Department of Orthopaedic Surgery, Copenhagen University Hospital - Amager and Hvidovre, Hvidovre, Denmark
Department of Clinical Medicine, University of Copenhagen, Copenhagen, Denmark

Search for other papers by Tazio Maleitzke in
Google Scholar
PubMed
Close
,
Carsten Perka Charité – Universitätsmedizin Berlin, corporate member of Freie Universität Berlin and Humboldt-Universität zu Berlin, Center for Musculoskeletal Surgery, Berlin, Germany

Search for other papers by Carsten Perka in
Google Scholar
PubMed
Close
,
Georg N Duda Charité – Universitätsmedizin Berlin, corporate member of Freie Universität Berlin and Humboldt-Universität zu Berlin, Center for Musculoskeletal Surgery, Berlin, Germany
Berlin Institute of Health at Charité – Universitätsmedizin Berlin, Julius Wolff Institute, Berlin, Germany
Berlin Institute of Health Center for Regenerative Therapies, Berlin Institute of Health at Charité – Universitätsmedizin Berlin, Berlin, Germany

Search for other papers by Georg N Duda in
Google Scholar
PubMed
Close
, and
Alexander Hildebrandt Charité – Universitätsmedizin Berlin, corporate member of Freie Universität Berlin and Humboldt-Universität zu Berlin, Center for Musculoskeletal Surgery, Berlin, Germany
Berlin Institute of Health at Charité – Universitätsmedizin Berlin, Julius Wolff Institute, Berlin, Germany

Search for other papers by Alexander Hildebrandt in
Google Scholar
PubMed
Close

  • Advanced therapies are expected to play a crucial role in supporting repair after injury, halting the degeneration of musculoskeletal tissue to enable and promote physical activity.

  • Despite advancements, the progress in developing advanced therapies in orthopaedics lags behind specialties like oncology, since innovative regenerative treatment strategies fall short of their expectations in musculoskeletal clinical trials.

  • Researchers should focus on understanding the mechanism of action behind the investigated target before conducting clinical trials.

  • Strategic research networks are needed that not only enhance scientific exchange among like-minded researchers but need to include early on commercial views, companies and venture perspectives, regulatory insights and reimbursement perspectives. Only in such collaborations essential roadblocks towards clinical trials and go-to-patients be overcome.

Open access
Arya Nicum Institute of Orthopaedics and Musculoskeletal Science, University College London, UK

Search for other papers by Arya Nicum in
Google Scholar
PubMed
Close
,
Harry Hothi Royal National Orthopaedic Hospital, Stanmore, UK.
Department of Mechanical Engineering, University College London, UK

Search for other papers by Harry Hothi in
Google Scholar
PubMed
Close
,
Johann Henckel Royal National Orthopaedic Hospital, Stanmore, UK.

Search for other papers by Johann Henckel in
Google Scholar
PubMed
Close
,
Anna di Laura Royal National Orthopaedic Hospital, Stanmore, UK.
Department of Mechanical Engineering, University College London, UK

Search for other papers by Anna di Laura in
Google Scholar
PubMed
Close
,
Klaus Schlueter-Brust Department of Orthopaedic Surgery, St. Franziskus Hospital Köln, Köln, Germany

Search for other papers by Klaus Schlueter-Brust in
Google Scholar
PubMed
Close
, and
Alister Hart Institute of Orthopaedics and Musculoskeletal Science, University College London, UK
Royal National Orthopaedic Hospital, Stanmore, UK.
Cleveland Clinic London, London, UK

Search for other papers by Alister Hart in
Google Scholar
PubMed
Close

  • Three-dimensional printing is a rapidly growing manufacturing method for orthopaedic implants and it is currently thriving in several other engineering industries. It enables the variation of implant design and the construction of complex structures which can be exploited in orthopaedics and other medical sectors.

  • In this review, we develop the vocabulary to characterise 3D printing in orthopaedics from terms defined by industries employing 3D printing, and by fully examining a 3D-printed off-the-shelf acetabular cup (Fig. 1). This is a commonly used 3D-printed implant in orthopaedics, and it exhibits a range of prominent features brought about by 3D printing.

  • The key features and defects of the porous and dense regions of the implant are clarified and discussed in depth to determine reliable definitions and a common understanding of characteristics of 3D printing between engineers and medical experts in orthopaedics.

  • Despite the extensive list of terminology derived here, it is clear significant gaps exist in the knowledge of this field. Therefore, it is necessary for continued investigations of unused implants, but perhaps more significantly, examining those in vivo and retrieved to understand their long-term impact on patients and the effects of certain features (e.g. surface-adhered particles).

  • Analyses of this kind will establish an understanding of 3D printing in orthopaedics and additionally it will help to update the regulatory approach to this new technology.

Open access
Alessandro Bensa Service of Orthopaedics and Traumatology, Department of Surgery, EOC, Lugano, Switzerland

Search for other papers by Alessandro Bensa in
Google Scholar
PubMed
Close
,
Alessandro Sangiorgio Service of Orthopaedics and Traumatology, Department of Surgery, EOC, Lugano, Switzerland

Search for other papers by Alessandro Sangiorgio in
Google Scholar
PubMed
Close
,
Angelo Boffa Applied and Translational Research (ATR) Center, IRCCS Istituto Ortopedico Rizzoli, Bologna, Italy

Search for other papers by Angelo Boffa in
Google Scholar
PubMed
Close
,
Manuela Salerno Applied and Translational Research (ATR) Center, IRCCS Istituto Ortopedico Rizzoli, Bologna, Italy

Search for other papers by Manuela Salerno in
Google Scholar
PubMed
Close
,
Giacomo Moraca Service of Orthopaedics and Traumatology, Department of Surgery, EOC, Lugano, Switzerland

Search for other papers by Giacomo Moraca in
Google Scholar
PubMed
Close
, and
Giuseppe Filardo Service of Orthopaedics and Traumatology, Department of Surgery, EOC, Lugano, Switzerland
Applied and Translational Research (ATR) Center, IRCCS Istituto Ortopedico Rizzoli, Bologna, Italy
Università della Svizzera Italiana, Faculty of Biomedical Sciences, Lugano, Switzerland

Search for other papers by Giuseppe Filardo in
Google Scholar
PubMed
Close

Purpose

  • Intra-articular corticosteroid (CS) injections for knee osteoarthritis (OA) management are endorsed by several scientific societies, while the use of hyaluronic acid (HA) and platelet-rich plasma (PRP) is more controversial. Aim of the study was to quantify and compare the clinical effectiveness of CS injections with respect to HA and PRP in patients with knee OA.

Methods

  • The search was conducted on PubMed, Cochrane, and Web of Science following the PRISMA guidelines. Randomized controlled trials (RCTs) on the comparison of CS injections and HA or PRP injections for the treatment of knee OA were included. The minimal clinically important difference (MCID) was used to interpret the clinical relevance of the improvements at different follow-ups up to 12 months. The study quality was assessed using the Cochrane RoB-2 tool and the GRADE guidelines.

Results

  • Thirty-five RCTs were included (3348 patients). The meta-analysis comparing CS and HA revealed no difference in terms of WOMAC improvement, while HA showed superior VAS pain improvement at long-term follow-up (P = 0.011), without reaching the MCID. PRP offered a superior WOMAC improvement compared to CS at short- (P = 0.002), mid- (P < 0.001, exceeding the MCID), and long-term (P < 0.001, exceeding the MCID) follow-ups. PRP offered a superior VAS improvement at mid- (P < 0.001, exceeding the MCID) and long-term (P = 0.023) follow-ups.

Conclusion

  • CS injections for knee OA offer similar results to HA and PRP only at short term, while there is an overall superiority of PRP at longer follow-ups. This difference is not only statistically significant but also clinically relevant in favour of PRP.

Open access
Yingze Su Department of Orthopaedics, Xinhua Hospital affiliated to Shanghai Jiao Tong University School of medicine, Yangpu District, Shanghai, People’s Republic of China

Search for other papers by Yingze Su in
Google Scholar
PubMed
Close
,
Kangming Chen Department of Orthopaedics, Huashan Hospital, Fudan University, Jing’an, Shanghai, People’s Republic of China

Search for other papers by Kangming Chen in
Google Scholar
PubMed
Close
,
Jinyan Wu Department of Orthopaedics, Xinhua Hospital affiliated to Shanghai Jiao Tong University School of medicine, Yangpu District, Shanghai, People’s Republic of China

Search for other papers by Jinyan Wu in
Google Scholar
PubMed
Close
,
Junfeng Zhu Department of Orthopaedics, Xinhua Hospital affiliated to Shanghai Jiao Tong University School of medicine, Yangpu District, Shanghai, People’s Republic of China

Search for other papers by Junfeng Zhu in
Google Scholar
PubMed
Close
, and
Xiaodong Chen Department of Orthopaedics, Xinhua Hospital affiliated to Shanghai Jiao Tong University School of medicine, Yangpu District, Shanghai, People’s Republic of China

Search for other papers by Xiaodong Chen in
Google Scholar
PubMed
Close

  • Femoral version (FV) is more widely adopted with the definition as the angle between the long axis of the femoral neck and the tangent line of the posterior femoral condyles on the axial plane, and the normal range between 5 and 20°.

  • FV can be measured by imaging and functional tests. Cross-sectional CT including both the hip and the knee is the typically used imaging technique, yet variation exists according to the different landmarks used. As MRI investigations are routinely performed preoperatively, and protocols can be easily adopted to include version measurement, they are frequently used as an alternative to CT and offers several advantages.

  • Abnormal FV has adverse effects on the biomechanics and musculoskeletal health of the whole lower limb. It affects the lever arm of muscles and the forces that the hip and patellofemoral joints suffer, and can lead to disorders such as osteoarthritis and impingement.

  • In adult hip preservation surgery for developmental dysplasia of the hip (DDH), abnormal FV is sometimes accompanied by other morphological abnormities of the hip, a more severe DDH, and can help predict postoperative range of motion (ROM), and postoperative impingement.

  • Currently, the most frequently used surgical technique for abnormal FV is femoral derotational osteotomy.

  • Many controversies are left to be solved, including the specific origin of FV, the indication for femoral derotational osteotomy, especially in patients with combined DDH and abnormal FV, and the explicit compensation mechanism of abnormal FV by tibial torsion.

Open access
Qiuyuan Wang Department of Evidence-based Medicine, Luoyang Orthopedic Hospital of Henan Province. Orthopedic Hospital of Henan Province, Luoyang, China
Department of Bone And Joint Diseases, Luoyang Orthopedic Hospital of Henan Province. Orthopedic Hospital of Henan Province, Luoyang, China

Search for other papers by Qiuyuan Wang in
Google Scholar
PubMed
Close
,
Feng Li Department of Bone And Joint Diseases, Luoyang Orthopedic Hospital of Henan Province. Orthopedic Hospital of Henan Province, Luoyang, China

Search for other papers by Feng Li in
Google Scholar
PubMed
Close
,
Yidan Yang Department of Evidence-based Medicine, Luoyang Orthopedic Hospital of Henan Province. Orthopedic Hospital of Henan Province, Luoyang, China

Search for other papers by Yidan Yang in
Google Scholar
PubMed
Close
,
Chen Yue Department of Evidence-based Medicine, Luoyang Orthopedic Hospital of Henan Province. Orthopedic Hospital of Henan Province, Luoyang, China

Search for other papers by Chen Yue in
Google Scholar
PubMed
Close
, and
Jiayi Guo Department of Evidence-based Medicine, Luoyang Orthopedic Hospital of Henan Province. Orthopedic Hospital of Henan Province, Luoyang, China
Department of Bone And Joint Diseases, Luoyang Orthopedic Hospital of Henan Province. Orthopedic Hospital of Henan Province, Luoyang, China

Search for other papers by Jiayi Guo in
Google Scholar
PubMed
Close

Purpose

  • Although magnesium sulfate (MgSO4) is widely used as an analgesic adjuvant to peripheral analgesic cocktails, its efficacy in total knee arthroplasty (TKA) is still controversial. Therefore, we systematically reviewed and meta-analyzed the literature to assess the analgesic efficacy of MgSO4 as an adjuvant to the analgesic cocktail in TKA.

Methods

  • The PubMed, EMBASE, Web of Science, and Cochrane Library databases were searched. The meta-analysis was performed according to the PRISMA guidelines. Data were qualitatively synthesized or meta-analyzed using a random-effects model.

Results

  • Five randomized controlled trials involving 432 patients were included. Meta-analyses detected significant differences between the MgSO4 and control groups in the visual analog scale (VAS) pain scores (rest) at 6, 12, and 24 h postoperatively; VAS pain scores (motion) at 12, 24, and 48 h postoperatively; morphine consumption within 24 h, 24–48 h, and during the total hospitalization period; time to first rescue analgesia after TKA; and length of hospital stay. Regarding the functional recovery, the meta-analysis demonstrated significant differences between groups in terms of knee range of motion on postoperative day 1; daily mobilization distance on postoperative day 1; and daily mobilization distance. There was no significant intergroup difference in surgical complications.

Conclusion

  • The findings suggest that MgSO4 is a promising adjunct to the analgesic cocktail, achieving significant improvements in pain scores and total opioid consumption during the early postoperative period after TKA.

Open access
Gyula Domos Department of Orthopaedics, Semmelweis University, Budapest, Hungary
Centre for Translational Medicine, Semmelweis University, Budapest, Hungary

Search for other papers by Gyula Domos in
Google Scholar
PubMed
Close
,
Szilárd Váncsa Centre for Translational Medicine, Semmelweis University, Budapest, Hungary
Institute for Translational Medicine, Medical School, University of Pécs, Pécs, Hungary
Institute of Pancreatic Diseases, Semmelweis University, Budapest, Hungary

Search for other papers by Szilárd Váncsa in
Google Scholar
PubMed
Close
,
Csenge Szeverényi Department of Orthopaedics, University of Debrecen, Debrecen, Hungary

Search for other papers by Csenge Szeverényi in
Google Scholar
PubMed
Close
,
Gergely Agócs Department of Biophysics and Radiation Biology, Semmelweis University, Budapest, Hungary

Search for other papers by Gergely Agócs in
Google Scholar
PubMed
Close
,
Péter Hegyi Centre for Translational Medicine, Semmelweis University, Budapest, Hungary
Institute for Translational Medicine, Medical School, University of Pécs, Pécs, Hungary
Institute of Pancreatic Diseases, Semmelweis University, Budapest, Hungary

Search for other papers by Péter Hegyi in
Google Scholar
PubMed
Close
,
Anna Perge Department of Orthopaedics, Semmelweis University, Budapest, Hungary

Search for other papers by Anna Perge in
Google Scholar
PubMed
Close
,
Krisztina Békési Klinik Chirurgie, Spital Bülach, Bülach, Switzerland

Search for other papers by Krisztina Békési in
Google Scholar
PubMed
Close
,
Csaba Varga Department of Orthopaedics, Semmelweis University, Budapest, Hungary
Centre for Translational Medicine, Semmelweis University, Budapest, Hungary

Search for other papers by Csaba Varga in
Google Scholar
PubMed
Close
, and
György Szőke Department of Orthopaedics, Semmelweis University, Budapest, Hungary

Search for other papers by György Szőke in
Google Scholar
PubMed
Close

Objective

  • In developmental dysplasia of the hip (DDH), concentric reduction of dislocated hips cannot be achieved by closed reduction in many cases, and open reduction is required (‘failure of reduction’). The incidence of cases requiring open reduction and the significance of risk factors for unsuccessful reduction remain unclear. We investigated the overall rate and the risk factors for failed closed reduction in DDH.

Methods

  • We followed the Cochrane recommendations in our systematic review and meta-analysis. We performed a systematic search in three medical databases to identify all studies reporting on pediatric patients with hip dislocation in DDH on 2 July 2022. Eligible studies reported on the rate of failure in children younger than 36 months. We calculated odds ratios (ORs) with 95% CIs from two-by-two tables (event rate in risk group, event rate in non-risk group).

Results

  • We identified 13 316 studies and included 62 studies (5281 hips) for failure rate and 34 studies (3810 hips) for risk factor analysis. The overall rate of failure in closed reduction was 20%. The risk of failure of reduction increased with the grade of dislocation and was significantly higher for high dislocations (group 0–24: IHDI 4 vs IHDI 2 OR: 17.45, CI: 9.26–32.92; Tönnis 4 vs Tönnis 2 OR: 14.67, CI: 1.21–177.37; Graf IV vs Graf III OR: 3.4, CI: 2.27–5.09). Male gender was also a significant risk factor (OR: 2.27, CI: 1.13–4.56) in group 0–36.

Conclusion

  • Higher grade dislocations and male gender are significant risk factors for failure of reduction in closed reduction in hip dislocation in DDH.

Open access
Djandan Tadum Arthur Vithran Department of Orthopedics, Xiangya Hospital, Central South University, Changsha, Hunan, China
National Clinical Research Center for Geriatric Disorders, Xiangya Hospital, Central South University, Changsha, China

Search for other papers by Djandan Tadum Arthur Vithran in
Google Scholar
PubMed
Close
,
Anko Elijah Essien Department of Orthopedics, Xiangya Hospital, Central South University, Changsha, Hunan, China

Search for other papers by Anko Elijah Essien in
Google Scholar
PubMed
Close
,
Masoud Rahmati Research Centre on Health Services and Quality of Life, Aix Marseille University, Marseille, France
Department of Physical Education and Sport Sciences, Faculty of Literature and Human Sciences, Lorestan University, Khoramabad, Iran
Department of Physical Education and Sport Sciences, Faculty of Literature and Humanities, Vali-E-Asr University of Rafsanjan, Rafsanjan, Iran

Search for other papers by Masoud Rahmati in
Google Scholar
PubMed
Close
,
Michael Opoku Department of Orthopedics, Xiangya Hospital, Central South University, Changsha, Hunan, China

Search for other papers by Michael Opoku in
Google Scholar
PubMed
Close
,
Dong Keon Yon Center for Digital Health, Medical Science Research Institute, Kyung Hee University Medical Center, Kyung Hee University College of Medicine, Seoul, Republic of Korea
Department of Pediatrics, Kyung Hee University College of Medicine, Seoul, Republic of Korea

Search for other papers by Dong Keon Yon in
Google Scholar
PubMed
Close
,
Guillermo F López Sánchez Division of Preventive Medicine and Public Health, Department of Public Health Sciences, School of Medicine, University of Murcia, Murcia, Spain

Search for other papers by Guillermo F López Sánchez in
Google Scholar
PubMed
Close
,
Ai Koyanagi Research and Development Unit, Parc Sanitari Sant Joan de Deu, Barcelona, Spain

Search for other papers by Ai Koyanagi in
Google Scholar
PubMed
Close
,
Lee Smith Centre for Health, Performance, and Wellbeing, Anglia Ruskin University, Cambridge, UK

Search for other papers by Lee Smith in
Google Scholar
PubMed
Close
,
Jae Il Shin Department of Pediatrics, Yonsei University College of Medicine, Seoul, Republic of Korea

Search for other papers by Jae Il Shin in
Google Scholar
PubMed
Close
,
Wenfeng Xiao Department of Orthopedics, Xiangya Hospital, Central South University, Changsha, Hunan, China
National Clinical Research Center for Geriatric Disorders, Xiangya Hospital, Central South University, Changsha, China

Search for other papers by Wenfeng Xiao in
Google Scholar
PubMed
Close
,
Shuguang Liu Department of Joint Surgery, Honghui Hospital, Xi’an Jiaotong University, Xi’an, Shaanxi, China

Search for other papers by Shuguang Liu in
Google Scholar
PubMed
Close
, and
Yusheng Li Department of Orthopedics, Xiangya Hospital, Central South University, Changsha, Hunan, China
National Clinical Research Center for Geriatric Disorders, Xiangya Hospital, Central South University, Changsha, China

Search for other papers by Yusheng Li in
Google Scholar
PubMed
Close

Objective

  • The aim of the study was to evaluate the efficacy and safety of teriparatide compared to other treatments for postmenopausal osteoporosis.

Methods

  • A review of studies from 2000 to January 2023 analyzed randomized controlled trials on postmenopausal women treated with teriparatide (PTH 1–34), comparing it to placebo or other osteoporosis treatments. The analysis focused on bone mineral density (BMD), bone turnover markers, and clinical outcomes, employing Review Manager 5.4.1 and the RoB 2 tool for bias assessment.

Results

  • Our analysis of 23 randomized controlled trials (RCTs) found that PTH (134) treatment significantly increased lumbar spine BMD (mean difference (MD) = 0.02, 95% CI: 0.01–0.03) and femoral neck BMD (MD = 0.01, 95% CI: 0.00–0.01). However, there were no significant changes in total hip and radial bone BMD among the 3536 and 2046 participants, respectively. We also found that PTH (1–34) increased P1NP in a larger cohort (n = 1415) when compared to osteocalcin (n = 206). Although the risk of adverse events increased (relative risk (RR) = 1.65, 95% CI: 1.32–2.07), the incidence of fractures decreased significantly (RR = 0.57, 95% CI: 0.45–0.072), with no significant difference observed in mortality rates between treatment and control groups.

Conclusion

  • Teriparatide improves lumbar spine and femoral neck BMD in postmenopausal women. Particularly notable is the novel finding regarding its effect on radius BMD, an area less explored in previous research. Despite an uptick in adverse events, the marked decrease in fracture incidence confirms its clinical utility for high-risk osteoporosis patients, highlighting the necessity for ongoing investigations into its full skeletal effects.

Open access
Abdelkader Shekhbihi Department of Trauma Surgery, Lörrach District Hospital, Baden-Württemberg, Lörrach, Germany

Search for other papers by Abdelkader Shekhbihi in
Google Scholar
PubMed
Close
,
Stefan Bauer Ensemble Hospitalier de la Côte, Morges, Switzerland.
School of Surgery, University of Western Australia, Perth, Australia

Search for other papers by Stefan Bauer in
Google Scholar
PubMed
Close
,
Arnaud Walch Chirurgie Orthopédique et Traumatologique du Membre Superieur, Hopital Edouard Herriot, Lyon, France

Search for other papers by Arnaud Walch in
Google Scholar
PubMed
Close
,
Winfried Reichert Department of Trauma Surgery, Lörrach District Hospital, Baden-Württemberg, Lörrach, Germany

Search for other papers by Winfried Reichert in
Google Scholar
PubMed
Close
,
Gilles Walch Ramsay Générale de Santé, Hôpital privé Jean Mermoz, Centre Orthopédique Santy, Lyon, France

Search for other papers by Gilles Walch in
Google Scholar
PubMed
Close
, and
Pascal Boileau Department of Orthopaedics and Sports Surgery, University Institute of Locomotion and Sports, Nice, France

Search for other papers by Pascal Boileau in
Google Scholar
PubMed
Close

  • The Trillat procedure, initially described by Albert Trillat, is historically one of the first techniques for addressing recurrent anterior shoulder instability, incorporating fascinating biomechanical mechanisms.

  • After lowering, medializing, and fixing the coracoid process to the glenoid neck, the subcoracoid space is reduced, the subscapularis lowered, and its line of pull changed, accentuating the function of the subscapularis as a humeral head depressor centering the glenohumeral joint. Furthermore, the conjoint tendon creates a ‘seatbelt’ effect, preventing anteroinferior humeral head dislocation.

  • Even though contemporary preferences lean towards arthroscopic Bankart repair with optional remplissage, bone augmentation, and the Latarjet procedure, enduring surgical indications remain valid for the Trillat procedure, which offers joint preservation and superior outcomes in two distinct scenarios: (i) older patients with massive irreparable cuff tears and anterior recurrent instability with an intact subscapularis tendon regardless of the extent of glenoid bone loss; (ii) younger patients with instability associated shoulder joint capsule hyperlaxity without concomitant injuries (glenoid bone loss, large Hill–Sachs lesion).

  • Complications associated with the Trillat procedure include recurrent anterior instability, potential overtightening of the coracoid, leading to pain and a significant reduction in range of motion, risk of subcoracoid impingement, and restriction of external rotation by up to 10°, a limitation that is generally well-tolerated.

  • The Trillat procedure may be an effective alternative technique for specific indications and should remain part of the surgical armamentarium for addressing anterior shoulder instability.

Open access
Duy Nguyen Anh Tran The International Ph.D. Program in Medicine, College of Medicine, Taipei Medical University, Taipei, Taiwan
Department of Orthopedics, Faculty of Medicine, Can Tho University of Medicine and Pharmacy, Can Tho, Vietnam

Search for other papers by Duy Nguyen Anh Tran in
Google Scholar
PubMed
Close
,
Bao Tu Thai Nguyen The International Ph.D. Program in Medicine, College of Medicine, Taipei Medical University, Taipei, Taiwan
Department of Orthopedics, Faculty of Medicine, Can Tho University of Medicine and Pharmacy, Can Tho, Vietnam

Search for other papers by Bao Tu Thai Nguyen in
Google Scholar
PubMed
Close
,
Tan Thanh Nguyen Department of Orthopedics, Faculty of Medicine, Can Tho University of Medicine and Pharmacy, Can Tho, Vietnam

Search for other papers by Tan Thanh Nguyen in
Google Scholar
PubMed
Close
,
Yu-Pin Chen Department of Orthopedics, Taipei Municipal Wan-Fang Hospital, Taipei, Taiwan
Department of Orthopedics, School of Medicine, College of Medicine, Taipei Medical University, Taipei, Taiwan

Search for other papers by Yu-Pin Chen in
Google Scholar
PubMed
Close
, and
Yi-Jie Kuo Department of Orthopedics, Taipei Municipal Wan-Fang Hospital, Taipei, Taiwan
Department of Orthopedics, School of Medicine, College of Medicine, Taipei Medical University, Taipei, Taiwan

Search for other papers by Yi-Jie Kuo in
Google Scholar
PubMed
Close

Purpose

  • Studies have reported conflicting findings on the relationship between smoking and surgical site infection (SSI) post fixation for ankle and calcaneal fractures. This meta-analysis explored the effect of smoking on SSI incidence following open reduction and internal fixation (ORIF) of these fractures.

Methods

  • Full-text studies on smoking’s influence on post-ORIF SSI rates for closed ankle and calcaneal fractures were sourced from the PubMed, Embase, and Cochrane databases, with no consideration given to language or publication date. Study quality was appraised using the Newcastle–Ottawa Scale. Odds ratios (OR) and the corresponding 95% CIs were determined using random-effects models. This meta-analysis adhered to the PRISMA guidelines and was registered with PROSPERO (CRD42023429372).

Results

  • The analysis incorporated data from 16 cohort and case–control studies, totaling 41 944 subjects, 9984 of whom were smokers, with 956 SSI cases. Results indicated smokers faced a higher SSI risk (OR: 1.62; 95% CI: 1.32–1.97, P < 0.0001) post ORIF, with low heterogeneity (I 2 = 26%). Smoking was identified as a significant deep SSI risk factor (OR: 2.09; 95% CI: 1.42–3.09; P = 0.0002; I 2 = 31%). However, the subgroup analysis revealed no association between smoking and superficial SSI (OR: 1.05; 95% CI: 0.82–1.33; P = 0.70; I 2 = 0%).

Conclusion

  • Smoking is associated with increased SSI risk after ORIF for closed ankle and calcaneus fractures. Although no clear link was found between superficial SSI and smoking, the data underscore the negative influence of smoking on deep SSI incidence.

Open access
Martin C Jordan Department of Orthopaedic Traumatology, University Hospital Würzburg, Julius-Maximilians-University Würzburg, Würzburg, Germany
TraumaEvidence @ German Society for Trauma Surgery, Berlin, Germany

Search for other papers by Martin C Jordan in
Google Scholar
PubMed
Close
,
Konrad F Fuchs Department of Orthopaedic Traumatology, University Hospital Würzburg, Julius-Maximilians-University Würzburg, Würzburg, Germany

Search for other papers by Konrad F Fuchs in
Google Scholar
PubMed
Close
,
Steven C Herath Department for Traumatology and Reconstructive Surgery, BG Trauma Center, University of Tübingen, Tübingen, Germany

Search for other papers by Steven C Herath in
Google Scholar
PubMed
Close
,
Joachim Windolf TraumaEvidence @ German Society for Trauma Surgery, Berlin, Germany
Department of Orthopaedic and Traumatology, Medical Faculty and University Hospital Düsseldorf, Heinrich-Heine-University Düsseldorf, Düsseldorf, Germany

Search for other papers by Joachim Windolf in
Google Scholar
PubMed
Close
,
Rainer H Meffert Department of Orthopaedic Traumatology, University Hospital Würzburg, Julius-Maximilians-University Würzburg, Würzburg, Germany

Search for other papers by Rainer H Meffert in
Google Scholar
PubMed
Close
, and
Anne Neubert TraumaEvidence @ German Society for Trauma Surgery, Berlin, Germany
Department of Orthopaedic and Traumatology, Medical Faculty and University Hospital Düsseldorf, Heinrich-Heine-University Düsseldorf, Düsseldorf, Germany

Search for other papers by Anne Neubert in
Google Scholar
PubMed
Close

Purpose

  • To compare anterior plate fixation (SP fixation) both alone and in combination with an additional posterior sacroiliac screw (SP+SIS fixation) as a treatment for pelvic ring injuries with widening of the pubic symphysis and disruption to the anterior sacroiliac ligaments.

Methods

  • To find studies with pelvic ring injuries (APC II; B2.3d) and SP or SP+SIS fixation, a systematic literature review was conducted by searching four databases. A protocol was published a priori at Open Science Framework (https://doi.org/10.17605/OSF.IO/3YHAV). Exclusion criteria included perineal injuries, chronic instability of the symphysis, complete sacroiliac separation, and pediatric patients (age <18 years). Primary outcomes of interest were defined as implant failure, health-related quality of life, and revision rate.

Results

  • Altogether, 1861 studies were screened, and 40 studies qualified for full-text analysis. In total, 14 studies (two surveys, six biomechanical studies, and six retrospective clinical studies) were included. The surveys revealed that surgeons who had more recently begun practicing were more likely to use posterior fixation (SP+ISS). The biomechanical studies were heterogenous and did not yield a uniform pattern. In clinical studies, 117 patients (45%) received SP fixation, and 142 patients (55%) received SP+SIS fixation. Complications occurred in 31 SP patients (30%) and in five SP+SIS patients (3.5%).

Conclusion

  • A high risk of bias was uncovered, and reporting was found to be incomplete. SP+SIS may have the potential to improve outcomes, but the evidence remains too inconclusive to draw reliable recommendations.

Open access